- Home
- / Mizuho Medy
Mizuho Medy
Stock Price
¥1.6 K
2024-10-29
Market Capitalization
¥31.4 B
2024-10-29
Revenue
¥11.3 B
FY, 2025
Mizuho Medy Summary
Company Summary
- Overview
- Mizuho Medy (株式会社 ミズホメディー) diagnostic products. It offers influenza virus, clostridium difficile, coronavirus, pregnancy test, and mycoplasma nucleic acid kits.
- Type
- Public
- Status
- Active
- Founded
- 1977
- HQ
- Tosu, JP | view all locations
- Website
- https://www.mizuho-m.co.jp
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Tosu, Saga HQ
Japan
5-4 Fujinokimachi
Mizuho Medy Financials
Summary Financials
- Revenue (FY, 2025)
- ¥11.3B
- Gross profit (FY, 2025)
- ¥8.0B
- Net income (FY, 2025)
- ¥3.4B
- Cash (FY, 2025)
- ¥10.8B
- EBIT (FY, 2025)
- ¥4.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026